Other microarray studies have shown that CA12 expression is up-regulated in estrogen-dependent breast cancers[13], and is also associated with vitamin D-responsive subtypes of colon cancer cell lines[14], suggesting that CA12 is expressed in cells with specific functions and in terminally differentiated cells. This evidence concerns the gene CA12 and malignant colon neoplasm.